The Deloitte Center for Health Solutions' latest survey reveals that a significant majority of diagnostics manufacturers recognize the need to adapt to a B2B2C operational model to drive future growth, with 62% of executives highlighting this shift as crucial.
This transformation is underscored by a growing disconnect between manufacturers and healthcare providers. While providers identify test ordering as their primary challenge, manufacturers mistakenly focus on results interpretation. The consumerization of healthcare is influencing these dynamics, with 76% of providers indicating that patient-initiated testing will reshape the diagnostics landscape in the coming years. Furthermore, interoperability issues persist, as 74% of providers report disjointed database systems throughout the diagnostic process.
As the market evolves, diagnostics manufacturers must pivot from being mere product vendors to becoming integral workflow partners. This involves embedding AI into electronic health records (EHR) and automating processes to deliver personalized data to consumers. The research highlights three critical disconnects: manufacturers misalign their innovations with provider needs, neglect key clinical stakeholders, and rely on outdated engagement strategies. Addressing these gaps is essential for manufacturers to remain competitive in a rapidly changing environment.
Looking ahead, the urgency for integration and personalization is paramount. With 92% of providers exploring patient-initiated testing, the demand for seamless, actionable insights is increasing. Manufacturers that embrace integrated AI platforms and streamline their workflows will not only enhance their relevance but also secure a competitive edge in a consumer-driven market. Those that resist this change risk becoming mere commodity suppliers with limited influence over diagnostic trends.